Scientific Evidence that Precursors like Arginine and AAKG Yield Limited Nitric Oxide Output Lead to the Discovery of a new Nitric Oxide Super-Molecule.
In the development of eNOXIDE, the MuscleMeds research team undertook a massive review and evaluation of the Nitric Oxide (NO) precursor and stimulating products on the market and numerous Nitric Oxide research studies to determine the best way for boosting NO levels. After extensive review, MuscleMeds scientists discovered that the NO precursor and NO stimulating products were at best minimally effective in elevating NO in the bloodstream, with individual effectiveness results varying. A plethora of research indicates the dose-response limitations of using orally administered arginine or other arginine based compounds, such as Arginine, Arginine Alpha-Ketoglutarate (AAKG), Citrulline and other NO precursors and stimulators. For example, when reviewing the research conducted using arginine, it was found that in order to achieve some elevation of NO, very large dosages of arginine were required, using intravenous administration. Even more problematic, the research reveals that the oral dosage methods used by all supplements (capsules, tablets, powder mixes, liquid drinks, etc.) were much less effective compared to intravenous (I.V.) administration.
Other efficacy concerns related to using NO precursors and NO stimulators include the widespread practice of products containing low, ineffective dosages. For example, a typical effective dosage reported in the medical research report is 30 grams of arginine, administered intravenously (I.V.) all within 30 minutes. Compare this to the low, sub-optimum dosing common among most NO supplements, where 3 grams or less of Arginine or AAKG is administered. To make matters worse, in an effort to prolong the NO elevations many of these products make the mistake of using a 6-hour sustained release tablets. Sustaining a sub-optimal 3 gram dose over a 6-hour period translates into delivering an even more ineffective sub-optimal dosage of a mere 0.5 grams per hour. Moreover, factor in that oral arginine is estimated to be about 70% bioavailable by some experts, and your dosage becomes even more dismal and sub-optimal (0.35 grams per hour).
In light of the gap that existed between the research realities of requiring very high dosages of intravenously administered arginine and the low dosages found being used among many products in the marketplace, this motivated the MuscleMeds research team to explore new, effective ways of increasing NO levels in the bloodstream. The research team literally reviewed thousands of molecules and research studies in search of discovering a new, more effective way to increase NO levels in the bloodstream. This massive research effort culminated in the development of the new class of Nitric Oxide Super-Molecule contained in eNOXIDE.
Unlike conventional NO products that merely attempt to increase NO levels using precursor ingredients such as Arginine, AAKG or Citrulline, which must go through the complex biochemical pathway to produce only limited amounts of NO, eNOXIDE is designed to contain a Real NO functional group linked to a natural carrier molecule and utilizes natural enzymatic hydrolysis in the body to deliver pure exogenous Nitric Oxide into the bloodstream. eNOXIDE Nitric Oxide Super-Molecule is designed to work rapidly and deliver high levels of real Nitric Oxide (NO) into the bloodstream (findings based on indirect preliminary pilot study evaluation using blood pressure as an indicator of Nitric Oxide induced vasorelaxation).
This special eNOXIDE Nitric Oxide Super-Molecule structure is a major advancement over the older endogenous NO precursors or NO stimulation approaches, which rely on your body’s limited ability to convert and produce Nitric Oxide. Therefore, eNOXIDE administration guarantees the most potent and effective NO delivery into the bloodstream and muscle tissue.
To achieve Nitric Oxide Super-Molecule stability and delivery system goals, eNOXIDE utilizes a novel dual functional liposomal delivery system. The FastSorb liposomal-based technology helps to stabilize the bioactive, and upon administration is designed for rapid and high levels of absorption directly into the bloodstream primarily through buccal cavity (mouth) absorption. Oral mucosal delivery (transmucosally) is an alternative method of systemic nutrient delivery that offers several advantages, as the oral mucosa is highly vascularised. The eNOXIDE Super Molecules are absorbed through the oral mucosa and directly enter the systemic blood circulation, bypassing the gastrointestinal tract and first-pass metabolism in the liver.
|Amount Per Serving||Amt||%DV|
* % Daily Value is based on a 2,000 calorie diet. Your daily values may be higher or lower based on your calorie needs.
† Daily Value (DV) not established.
Bodyweight under 200 lbs. take 1 tablet. Bodyweight over 200 lbs. take 1 to 2 tablet(s). Ten minutes before your workout, place eNOXIDE FastSorb tablet(s) in mouth and let dissolve completely. Swallow after the tablet has completely dissolved.For healthy adults only. Do not exceed your recommended tablet dosage in a 12-hour period. Do not take more than 5 days per week. Do not take for more than 8 consecutive weeks. Maintain a level of good hydration while taking eNOXIDE.
NOT INTENDED FOR USE BY PERSONS WITH A MEDICAL CONDITION. NOT INTENDED FOR USE BY PERSONS UNDER AGE 18, OR PREGNANT OR LACTATING WOMEN.
Consult a physician or licensed qualified healthcare professional before using this product. Not for people with cardiovascular diseases, blood pressure problems, head injury or other diseases or disorders. Consult your physician prior to use if you have a medical condition, including, but not limited to, heart, kidney, liver or thyroid disease, psychiatric or epileptic disorders, difficulty urinating, diabetes, high or low blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Do not take with any medication, especially cardiovascular and erectile dysfunction medications, blood pressure drugs, heart or other cardiovascular system medications, antibiotics, antihistamines, benzocaine and lidocaine or other drugs. Do not take with other supplement products designed to increase Nitric Oxide levels or products containing over 75 mg of niacin per serving, or products containing yohimbine. Avoid alcohol consumption within 5 hours before and after taking eNOXIDE. Discontinue use immediately if you experience one or more of the following: dizziness, light headedness, severe headache, low blood pressure, rapid heartbeat, shortness of breath.
Discontinue use 2 weeks prior to surgery. Do not use for more than 5 days per week, or more than 8 consecutive weeks.